Variable | Concurrent mental and opioid use disorder | Opioid use disorder only | Standardized differences (sd) |
---|---|---|---|
 | N = 48,679 (87.0) | 7245 (13.0) |  |
Age | Â | Â | 0.3 |
 15 to 24 | 8.727 (17.9) | 1514 (20.9) |  |
 25 to 34 | 16,148 (33.2) | 2859 (39.5) |  |
 35 to 44 | 10,712 (22.0) | 1383 (19.1) |  |
 45 to 54 | 8812 (18.1) | 989 (13.7) |  |
 55 to 64 | 3348 (6.9) | 338 (4.7) |  |
 +65+ | 932 (1.9) | 162 (2.2) |  |
Sex | Â | Â | 0.2 |
 +Male | 30,654 (63.0) | 5575 (77.0) |  |
 Female | 18,025 (37.0) | 1670 (23.1) |  |
Geography | Â | Â | 0.2 |
 +Southern urban | 37,887 (77.8) | 5209 (71.9) |  |
 Northern rural | 2240 (4.6) | 593 (21.0) |  |
 Northern urban | 4533 (9.3) | 761 (10.5) |  |
 Southern rural | 4016 (8.2) | 682 (9.4) |  |
Income | Â | Â | 0.0 |
 +5 | 5532 (11.5) | 734 (10.4) |  |
 4 | 7014 (14.6) | 1078 (15.2) |  |
 3 | 8690 (18.1) | 1282 (18.1) |  |
 2 | 10,886 (22.6) | 1613 (22.7) |  |
 1 (lowest) | 16,020 (33.3) | 2388 (33.7) |  |
HIV positive | 390 (0.8) | 21 (0.3) | 0.1 |
Deep-tissue infection | 1584 (3.3) | 92 (1.3) | 0.1 |
All-cause mortality | 2485 (5.1) | 227 (3.1) | 0.1 |
*One year continuous OAT | 8757 (37.6) | 903 (35.7) | 0.2 |
*Mean days buprenorphine (SD) | 55.0 (167.8) | 34.8 (121.8) | < .0001 |
*Mean days methadone (SD) | 356.8 (441.0) | 344.6 (409.8) | < .0.042 |